APRE is Aprea Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.81. Market cap: $10M. Capital Quality Rank: 5/100 — Systemic risk.
Stock snapshot
| Price | $0.81 |
| Market cap | $10M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 5 / 100 · Systemic risk |
| Shareholder buyback yield | -15.73% |
| Altman Z-score zone | Distress |
About APRE
Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.
Related non-dividend companies
Other non-dividend stocks investors research alongside APRE. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is APRE's current stock price?
APRE (Aprea Therapeutics, Inc.) is currently trading at $0.81.
Does APRE pay a dividend?
APRE (Aprea Therapeutics, Inc.) does not currently pay a regular dividend.
What is APRE's Capital Quality Rank?
APRE has a Capital Quality Rank of 5/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track APRE in DiviDrip
Add APRE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search APRE and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.